J Clin Neurol.  2023 May;19(3):217-229. 10.3988/jcn.2022.0208.

Current Updates on the Diagnosis and Management of Multiple Sclerosis for the General Neurologist

Affiliations
  • 1Department of Neurology, University of Chicago, Chicago, IL, USA
  • 2Division of Neuroimmunology, Division of Neuroinfectious Diseases, Northwestern University, Chicago, IL, USA
  • 3Division of Neuroimmunology, Rush University, Chicago, IL, USA

Abstract

Multiple sclerosis (MS) is an immune-driven disease that affects the central nervous system and is characterized by acute-on-chronic demyelination attacks. It is a major cause of global neurological disability, and its prevalence has increased in the United States. Conceptual understandings of MS have evolved over time, including the identification of B cells as key factors in its pathophysiology. The foundation of MS management involves preventing flares so as to avoid long-term functional decline. Treatments may be categorized into low-, middle-, and high-efficacy medications based on their efficacy in relapse prevention. With 24 FDAapproved treatments for MS, individual therapy is chosen based on distinct mechanisms and potential side effects. This review provides a detailed update on the epidemiology, diagnosis, treatment advances, and major ongoing research investigations in MS.

Keyword

multiple sclerosis; review; neuroimmunology; autoimmune neurology
Full Text Links
  • JCN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr